TNF and inflammatory bowel disease: In Salvador-Martín et al., which included 33 children, expression of SMAD7, FCGR1A, FCGR1B, and GBP1 was found to be a pharmacogenomic biomarker of early response to anti-TNF agents in children with IBD.